カテゴリ： MarketLine, アメリカ, 企業調査

Gilead Sciences, Inc.：企業の戦略・SWOT・財務情報

◆英語タイトル：Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C15225
◆発行会社（調査会社）：MarketLine
◆発行日：2019年3月
◆ページ数：63
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Gilead Sciences, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Gilead Sciences, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Gilead Sciences, Inc. (Gilead or ‘the company’) is a research based biopharmaceutical company engaged in developing and marketing therapies for HIV/AIDS, liver diseases, oncology, inflammation and serious cardiovascular and respiratory conditions. The company offers its products through distributors andf subsidiaries. It offers products under the brands: AmBisome, Atripla, Cayston, Complera/Eviplera, Emtriva, Genvoya, Hepsera, Harvoni, Letairis, Lexiscan /Rapiscan, Macugen, Ranexa, Stribild, Tamiflu, Truvada, Tybost, Viread, Vitekta, Zydelig and Sovaldi. It also provides a range of pipeline products. The company has its operations in the US, Europe and other countries. The company is headquartered in Foster City, California, the US.

Scope

- Detailed information on Gilead Sciences, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Gilead Sciences, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Gilead Sciences, Inc. including a breakdown and examination of key business segments
- Intelligence on Gilead Sciences, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Gilead Sciences, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Gilead Sciences, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Gilead Sciences, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Gilead Sciences, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Gilead Sciences, Inc.: Company Overview
Gilead Sciences, Inc.: Overview and Key Facts
Gilead Sciences, Inc.: Overview
Gilead Sciences, Inc.: Key Facts
Gilead Sciences, Inc.: Key Employees
Gilead Sciences, Inc.: Key Employee Biographies
Gilead Sciences, Inc.: Major Products and Services
Gilead Sciences, Inc.: Company History
Gilead Sciences, Inc.: Management Statement
Gilead Sciences, Inc.: Locations and Subsidiaries
Gilead Sciences, Inc.: Key Competitors
Gilead Sciences, Inc.: Company Analysis
Gilead Sciences, Inc.: Business Description
Gilead Sciences, Inc.: SWOT Analysis
Gilead Sciences, Inc.: SWOT Overview
Gilead Sciences, Inc.: Strengths
Gilead Sciences, Inc.: Weaknesses
Gilead Sciences, Inc.: Opportunities
Gilead Sciences, Inc.: Threats
Gilead Sciences, Inc.: Corporate Financial Deals Activity
Gilead Sciences, Inc.: Financial Deals Overview
Gilead Sciences, Inc.: Targets and Partners
Gilead Sciences, Inc.: Top Deals 2015 – 2019YTD*
Gilead Sciences, Inc.: Advisors
Gilead Sciences, Inc.: Top Legal Advisors
Gilead Sciences, Inc.: Top Financial Advisors
Gilead Sciences, Inc.: Mergers and Acquisitions
Gilead Sciences, Inc.: Corporate Venturing
Gilead Sciences, Inc.: Capital Raising
Gilead Sciences, Inc.: Partnership
Gilead Sciences, Inc.: Recent Developments
Gilead Sciences, Inc.: News and Events Summary
Gilead Sciences, Inc.: Business Expansion
Gilead Sciences, Inc.: Business Reorganization
Gilead Sciences, Inc.: Contracts
Gilead Sciences, Inc.: Corporate Governance
Gilead Sciences, Inc.: Grants
Gilead Sciences, Inc.: Market Developments
Gilead Sciences, Inc.: Red Flags/Distress Signals
Gilead Sciences, Inc.: Regulatory and Legal Events
Gilead Sciences, Inc.: Research & Development
Gilead Sciences, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Gilead Sciences, Inc.: Key Facts
Table 2: Gilead Sciences, Inc.: Key Employees
Table 3: Gilead Sciences, Inc.: Company History
Table 4: Gilead Sciences, Inc.: Locations and Subsidiaries
Table 5: Gilead Sciences, Inc.: Key Competitors
Table 6: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Gilead Sciences, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Gilead Sciences, Inc.: Targets and Partners
Table 10: Gilead Sciences, Inc.: Top Deals 2015 - 2019YTD*
Table 11: Gilead Sciences, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Gilead Sciences, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Gilead Sciences, Inc.: M&A Volume and Value Trend (2015 - YTD*2019)
Table 14: Gilead Sciences, Inc.: M&A Activity by Geography (2015 - YTD*2019)
Table 15: Gilead Sciences, Inc.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 16: Gilead Sciences, Inc.: Corporate Venturing by Geography (2015 - YTD*2019)
Table 17: Gilead Sciences, Inc.: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 18: Gilead Sciences, Inc.: Capital Raising by Deal Type (2015 - YTD*2019)
Table 19: Gilead Sciences, Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 20: Gilead Sciences, Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 21: Gilead Sciences, Inc.: News and Events Summary
Table 22: Gilead Sciences, Inc.: Business Expansion
Table 23: Gilead Sciences, Inc.: Business Reorganization
Table 24: Gilead Sciences, Inc.: Contracts
Table 25: Gilead Sciences, Inc.: Corporate Governance
Table 26: Gilead Sciences, Inc.: Grants
Table 27: Gilead Sciences, Inc.: Market Developments
Table 28: Gilead Sciences, Inc.: Red Flags/Distress Signals
Table 29: Gilead Sciences, Inc.: Regulatory and Legal Events
Table 30: Gilead Sciences, Inc.: Research & Development
Table 31: Gilead Sciences, Inc.: Strategy and Operations

List of Figures
Figure 1: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 3: Gilead Sciences, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Gilead Sciences, Inc.: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 5: Gilead Sciences, Inc.: M&A Activity by Geography (2015 - YTD*2019)
Figure 6: Gilead Sciences, Inc.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Figure 7: Gilead Sciences, Inc.: Corporate Venturing by Geography (2015 - YTD*2019)
Figure 8: Gilead Sciences, Inc.: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Figure 9: Gilead Sciences, Inc.: Capital Raising by Deal Type (2015 - YTD*2019)
Figure 10: Gilead Sciences, Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 11: Gilead Sciences, Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)

★海外企業調査レポート[Gilead Sciences, Inc.：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • American Gene Technologies International Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary American Gene Technologies International Inc (AGT) is a drug development company that tests and commercializes gene-based drugs. The company develops therapies for the treatment of cancer, neurological disorders, AIDS, infectious diseases, Parkinson’s diseases, diabetes, familial dysautonomi …
  • Indra Sistemas SA (IDR)：企業の財務・戦略的SWOT分析
    Indra Sistemas SA (IDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • National Grid Plc (NG)：電力：M&Aディール及び事業提携情報
    Summary National Grid Plc (National Grid) is an energy utility. It transmits and distributes electricity and gas. The company owns and operates electricity and gas transmission and distribution networks; and is also the system operator for the Scottish networks. National Grid provides installation a …
  • Advanced Materials Enterprises Co Ltd：企業の製品パイプライン分析2018
    Summary Advanced Materials Enterprises Co Ltd (AME) is a laboratory equipment supplier. The company manufactures group of high precision mechanical components. It offers laboratory and professional equipment, consumer and lifestyle products, industrial heating system, and healthcare products. AME’s …
  • Biomm SA (BIOM3)：製薬・医療：M&Aディール及び事業提携情報
    Summary Biomm SA (Biomm), formerly Savicevic Participacoes SA is a biopharmaceutical company that research, develops, produces and markets biomedicines. The company develops processes for the production of active pharmaceutical ingredients and enzymes used in the production of biofuels. It licenses …
  • Jiangsu Hengrui Medicine Co Ltd (600276)：製薬・医療：M&Aディール及び事業提携情報
    Summary Jiangsu Hengrui Medicine Co Ltd (Jiangsu Hengrui) is a biopharmaceutical company that focuses on the research, development, manufacture and distribution of novel pharmaceutical products. Its product portfolio includes antineoplastic products, anti-tumor drugs, surgical drugs and contrast age …
  • TDC AS：企業の戦略的SWOT分析
    TDC AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Petronas Dagangan Bhd (PETDAG)：石油・ガス：M&Aディール及び事業提携情報
    Summary Petronas Dagangan Bhd (Petronas Dagangan), a subsidiary of Petroliam Nasional Berhad, is an oil and gas company that retails and markets downstream oil and gas products. The company operates through its business segments such as retail, commercial, liquefied petroleum gas and lubricants. It …
  • Huntington Ingalls Industries Inc：戦略・SWOT・企業財務分析
    Huntington Ingalls Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Huntington Ingalls Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Shenergy Co., Ltd. (600642)：電力：M&Aディール及び事業提携情報
    Summary Shenergy Company, Ltd. (Shenergy) is China-based gas and electricity company. The company is engaged in the construction, investment, operations and management of petroleum, natural gas and electric power. Its electricity projects include hydropower, coal-fired power and thermal power genera …
  • Nuo Therapeutics Inc (NUOTQ)-医療機器分野：企業M&A・提携分析
    Summary Nuo Therapeutics Inc (Nuo Therapeutics) is a biomedical company, which specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, which bind the regenerative capacity of the human body to trigger natural healing. The company's flagsh …
  • Citic Resources Holdings Limited：企業の戦略・SWOT・財務分析
    Citic Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Citic Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Copper Mountain Mining Corporation：企業の戦略・SWOT・財務情報
    Copper Mountain Mining Corporation - Strategy, SWOT and Corporate Finance Report Summary Copper Mountain Mining Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Deoleo SA：企業の戦略・SWOT・財務分析
    Deoleo SA - Strategy, SWOT and Corporate Finance Report Summary Deoleo SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Medrobotics Corp：医療機器：M&Aディール及び事業提携情報
    Summary Medrobotics Corp (Medrobotics), formerly Cardioborobotics Inc is a medical device company that develops flexible robot platforms for single-site surgical and interventional applications. The company provides flex robotic systems and flex retractor systems. Its flexible robot platform contain …
  • Itamar Medical Ltd (ITMR)：医療機器：M&Aディール及び事業提携情報
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that develops, markets and sells diagnostic medical devices for the diagnosis and treatment of sleep apnea. The company’s products include EndoPAT, a medical device for the diagnosis of endothelial dysfunction assessment tool fo …
  • Iovance Biotherapeutics Inc (IOVA)：企業の財務・戦略的SWOT分析
    Iovance Biotherapeutics Inc (IOVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Adventist Health System：企業の戦略的SWOT分析
    Adventist Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Emirates Retakaful Limited：企業の戦略・SWOT・財務情報
    Emirates Retakaful Limited - Strategy, SWOT and Corporate Finance Report Summary Emirates Retakaful Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • The British United Provident Association Ltd：企業の戦略的SWOT分析
    The British United Provident Association Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆